PO-1371 Dose-adaptive MR-linac workflow for hypofractionated focal boost radiotherapy in prostate cancer. (May 2022) - Kerkmeijer, L.; Kunze-Busch, M.; Smeenk, R.J.; Van Kollenburg, P.; Abbenhuis, L.; Scheenstra, T.; Engels, L.; Van der Sande, C.; Verheyden-Beckers, N.; Spee, L.; Hinke, L.; Brunenberg, E.; et al.